Jaime Brizuela

Jaime Brizuela

Auto-generated profile, based on publicly available information

Jaime Brizuela

Department of Global Health, Amsterdam Institute for Global Health and Development, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands; Department of Medical Microbiology and Infection Prevention, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2024 in Emerging Infectious Diseases
Verified
Journal Article
Open access
PDF file
JBJaime Brizuela
Jaime Brizuela
TRThomas J. Roodsant
Thomas J. Roodsant
QHQureisha Hasnoe
Qureisha Hasnoe
BPBoas C.L. van der Putten
Boas C.L. van der Putten
JKJana Kozakova
Jana Kozakova
CSConstance Schultsz
Constance Schultsz
Estimates of infection from this pathogen suggest a high health burden among persons handling pigs and pork products.

15 February 2023 in Microbial Genomics
Verified
Journal Article
Open access
JBJaime Brizuela
Jaime Brizuela
RKRattagan Kajeekul
Rattagan Kajeekul
TRThomas J. Roodsant
Thomas J. Roodsant
ARAthita Riwload
Athita Riwload
PBParichart Boueroy
Parichart Boueroy
Anusak KerdsinAnusak Kerdsin
Anusak Kerdsin
Streptococcus suisis an emerging zoonotic swine pathogen which can cause severe infections in humans. In March 2021, an outbreak ofS. suisinfections with 19 confirmed cases of septicemia and meningitis leading to two deaths, occurred in Nakhon Ratchasima province, Thailand. We characterized the outbreak through an epidemiological investigation combined with Illumina and Nanopore whole genome sequencing (WGS). The source of the outbreak was traced back to a raw pork dish prepared from a single pig during a Buddhist ceremony attended by 241 people. WGS analysis revealed that a singleS. suisserotype 2 strain belonging to a novel sequence type (ST) of the emergent Thai zoonotic clade CC233/379, was responsible for the infections. The outbreak clone grouped together with other Thai zoonotic strains from CC233/379 and CC104 in a globalS. suisphylogeny and capsule switching events between serotype 2 zoonotic strains and serotype 7 porcine strains were identified. The outbreak strain showed reduced susceptibility to penicillin corresponding with mutations in key residues in the penicillin binding proteins (PBPs). Furthermore, the outbreak strain was resistant to tetracycline, erythromycin, clindamycin, linezolid and chloramphenicol, having acquired an integrative and conjugative element (ICE) carrying resistance genestetOandermB,as well as a transposon from the IS1216 family carryingoptrAandermA. This investigation demonstrates that multi-drug resistant zoonotic lineages ofS. suiswhich pose a threat to human health continue to emerge.

16 January 2024 in Journal of Biological Chemistry
Verified
Journal Article
Open access
KEKira Eilers
Kira Eilers
JYJoey Kuok Hoong Yam
Joey Kuok Hoong Yam
XLXianghui Liu
Xianghui Liu
YGYu Fen Goh
Yu Fen Goh
KTKa-Ning To
Ka-Ning To
AFAlain Filloux
Alain Filloux
Bacterial lifestyles depend on conditions encountered during colonization. The transition between planktonic and biofilm growth is dependent on the intracellular second messenger c-di-GMP. High c-di-GMP levels driven by diguanylate cyclases (DGCs) activity favor biofilm formation, while low levels were maintained by phosphodiesterases (PDE) encourage planktonic lifestyle. The activity of these enzymes can be modulated by stimuli-sensing domains such as Per-ARNT-Sim (PAS). In Pseudomonas aeruginosa, more than 40 PDE/DGC are involved in c-di-GMP homeostasis, including 16 dual proteins possessing both canonical DGC and PDE motifs, that is, GGDEF and EAL, respectively. It was reported that deletion of the EAL/GGDEF dual enzyme PA0285, one of five c-di-GMP-related enzymes conserved across all Pseudomonas species, impacts biofilms. PA0285 is anchored in the membrane and carries two PAS domains. Here, we confirm that its role is conserved in various P. aeruginosa strains and in Pseudomonas putida. Deletion of PA0285 impacts the early stage of colonization, and RNA-seq analysis suggests that expression of cupA fimbrial genes is involved. We demonstrate that the C-terminal portion of PA0285 encompassing the GGDEF and EAL domains binds GTP and c-di-GMP, respectively, but only exhibits PDE activity in vitro. However, both GGDEF and EAL domains are important for PA0285 PDE activity in vivo. Complementation of the PA0285 mutant strain with a copy of the gene encoding the C-terminal GGDEF/EAL portion in trans was not as effective as complementation with the full-length gene. This suggests the N-terminal transmembrane and PAS domains influence the PDE activity in vivo, through modulating the protein conformation.

24 December 2024 in Diagnostic Microbiology and Infectious Disease
Verified
Journal Article
Open access
JBJaime Brizuela
Jaime Brizuela
KKKoos Korsten
Koos Korsten
TRTessel M. van Rossen
Tessel M. van Rossen
CSConstance Schultsz
Constance Schultsz
Streptococcus suis is a porcine pathogen that causes severe zoonotic infections in humans resulting in meningitis and sepsis. The main risk factors for S. suis zoonotic infections are consumption of raw pork products and direct contact with live pigs or pork, in particular in the presence of skin injuries. Most human infections are caused by clonal complex 1 (CC1) serotype 2 isolates. We describe an unusual case of S. suis bacteraemia caused by a CC1 strain carrying a serotype 14 capsule in a patient without a history of consumption of raw pork products or contact with either pig or pork. The isolate formed a serotype 14 clade with three German serotype 14 strains that has diverged from the main CC1 serotype 2 lineage. This is the first report of a human infection caused by a serotype 14 S. suis in the Netherlands, which in combination with its unknown transmission route and severity of the disease, calls for its notification.

14 March 2026 in Clinical Microbiology and Infection
Verified
Journal Article
Open access
JBJaime Brizuela
Jaime Brizuela
GMGemma G.R. Murray
Gemma G.R. Murray
PBParichart Boueroy
Parichart Boueroy
ABAndrew J. Balmer
Andrew J. Balmer
TWThidathip Wongsurawat
Thidathip Wongsurawat
CSConstance Schultsz
Constance Schultsz
Streptococcus suis is an emerging zoonotic porcine pathogen and a leading cause of adult bacterial meningitis in Southeast Asia, associated with raw pork consumption. Most zoonotic S. suis infections globally are caused by strains from lineage CC1 carrying a serotype 2 capsule. However, in Thailand, ∼40% of the reported zoonotic infections are caused by two endemic lineages, CC104 and CC233 which also have a serotype 2 capsule. In this study, we aimed to identify the drivers of the emergence and recent evolution of these two lineages. We sequenced the whole genomes of 141 Thai S. suis zoonotic and porcine strains isolated over a 15-year period and combined them with a curated global dataset of 2761 published S. suis genomes. Using comparative genomics, Bayesian evolutionary models and multivariate analysis we investigated the emergence of zoonotic potential and multi-drug resistance in CC104 and CC233. We estimated recent emergence dates for both CC104 (1990; 95% posterior: 1987-1992) and CC233 (2002; 95% posterior: 2000-2004). Both lineages acquired a serotype capsule 2 from CC1 through a capsule locus switching event, prior to their emergence. Both lineages have also experienced multiple antimicrobial resistance (AMR) acquisition events, with some strains carrying 12 determinants encoding resistance against eight classes of antibiotics. Most importantly, CC104 and CC233 lineages are the first zoonotic lineages to have acquired increased resistance to penicillin and ceftriaxone, which form the standard therapy to treat S. suis infections in humans. Horizontal transfer of multiple genomic regions can cause rapid emergence of novel multi-drug-resistant zoonotic S. suis lineages. As S. suis is mainly controlled and treated through the use of antibiotics in both pigs and humans, these findings highlight the urgent need for improved and enhanced surveillance, infection control, and treatments.

1 July 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
JBJaime Brizuela
Jaime Brizuela
GMGemma Murray
Gemma Murray
PBParichart Boueroy
Parichart Boueroy
ABAndrew J. Balmer
Andrew J. Balmer
TWThidathip Wongsurawat
Thidathip Wongsurawat
CSConstance Schultsz
Constance Schultsz
Background: Streptococcus suis is an emerging zoonotic porcine pathogen and a leading cause of adult bacterial meningitis in Southeast Asia, associated with raw pork consumption. Most zoonotic S. suis infections globally are by strains from lineage CC1 carrying a serotype 2 capsule. However, in Thailand, ∼40% of the reported zoonotic infections are caused by two endemic lineages, CC104 and CC233 which also have a serotype 2 capsule. In this study, we aimed to identify the drivers of the emergence and recent evolution of these two lineages. Methods: We sequenced the whole genomes of 141 Thai S. suis zoonotic and porcine strains isolated over a 15-year period and combined them with a curated global dataset of 2761 published S. suis genomes. Using comparative genomics, Bayesian evolutionary models and multivariate analysis we investigated the emergence of zoonotic potential and multi-drug resistance in CC104 and CC233. Findings: We estimated recent emergence dates for both CC104 (1990; 95% posterior: 1987-1992) and CC233 (2002; 95% posterior: 2000-2004). Both lineages acquired a serotype capsule 2 from CC1 through a capsule locus switching event, prior to their emergence. Both have also experienced multiple antimicrobial resistance (AMR) acquisition events, with some strains carrying 12 determinants encoding resistance against eight classes of antibiotics. Most importantly, CC104 and CC233 lineages are the first zoonotic lineages to have acquired increased resistance to penicillin and ceftriaxone, which form the standard therapy to treat S. suis infections in humans. Interpretation: Horizontal transfer of multiple genomic regions can cause rapid emergence of novel multi-drug-resistant zoonotic S. suis lineages. As S. suis is mainly controlled and treated through the use of antibiotics in both pigs and humans, these findings highlight the urgent need for improved and enhanced surveillance, infection control, and treatments.